gyki 52466 has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rothstein, JD | 1 |
| Bristol, LA | 1 |
| Hosler, B | 1 |
| Brown, RH | 1 |
| Kuncl, RW | 1 |
| Vartiainen, N | 1 |
| Tikka, T | 1 |
| Keinänen, R | 1 |
| Chan, PH | 1 |
| Koistinaho, J | 1 |
2 other studies available for gyki 52466 and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons.
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Anti-Anxiety Agents; Antio | 1994 |
Glutamatergic receptors regulate expression, phosphorylation and accumulation of neurofilaments in spinal cord neurons.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amyo | 1999 |